Answers are grounded in this paper and cite their sources.
The aim of the study. To assess the possible impact of trophectoderm biopsy on obstetric and perinatal outcomes of pregnancies resulting from the transfer of a thawed embryo in assisted reproductive technology programs. Material and methods. A retrospective single-center study was conducted, including analysis of medical records and a telephone survey of patients with confirmed clinical pregnancy after single thawed embryo transfer in 2020—2021. The possible impact of trophectoderm biopsy performed during preimplantation genetic testing for aneuploidies (PGT-A) on the course of pregnancy, obstetric and perinatal outcomes was analyzed. The study included data from 190 patients: 95 patients in the PGT-A group and 95 in the control group. Results. Isthmic-cervical insufficiency was observed more frequently in the PGT-A group (OR=2.54; 95% CI 1.04–6.21, p=0.034). A borderline statistically significant increase in placenta previa incidence was also noted (OR=6.34; 95% CI 0.75–53.69, p=0.054). No statistically significant differences were found between the PGT-A and control groups in terms of cesarean section rates, major obstetric syndromes, neonatal anthropometrics, or frequency of fetal malformations. Conclusion. Trophectoderm biopsy during preimplantation genetic testing may increase the risk of placenta previa and accreta, as well as isthmic-cervical insufficiency. Additional studies are needed to confirm or refute these results.
No takes yet. Share an insight, caveat, or question.
Лисицына et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: